![Yoshitsuga Shitaka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshitsuga Shitaka
President bij OCATA THERAPEUTICS INC
Actieve functies van Yoshitsuga Shitaka
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OCATA THERAPEUTICS INC | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
President | - | - | |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Algemeen Directeur | - | - |
Loopbaan van Yoshitsuga Shitaka
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Astellas Institute for Regenerative Medicine
![]() Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
- Beurs
- Insiders
- Yoshitsuga Shitaka
- Ervaring